XENOMUNE

kits for use in pig to human organ transplants comprising one or more of the following components - porcine bone marrow cells; myelosuppressive agents; antibodies to deplete organ transplant recipient's T cells and NK cells; cytokines; gene therapy vector, namely, a carrier molecule for expressing a gene; and porcine organs